טוען...
Two cases of liver cirrhosis treated with lusutrombopag before partial splenic embolization
Lusutrombopag, a small molecule thrombopoietin receptor agonist, has been approved for the treatment of chronic liver disease-associated thrombocytopenia due to hypersplenism in patients scheduled to undergo elective invasive procedures in Japan. We performed partial splenic embolization (PSE) after...
שמור ב:
| הוצא לאור ב: | Fukushima J Med Sci |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Fukushima Society of Medical Science
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5792501/ https://ncbi.nlm.nih.gov/pubmed/29142151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5387/fms.2017-07 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|